Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00289523 · ClinicalTrials.gov registry record
EEG Biomarkers for Predicting Response to Antidepressant Therapy
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 375
- Enrollment target
NCT00289523 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 375 participants.
The verdict
NCT00289523 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 375 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the potential early EEG predictors of an individual's response to treatment with antidepressant medications. Objectives: * Prospectively confirm accuracy of current EEG biomarker algorithm * Determine preferred clinical intervention for subjects with negative indicator * Identify predictors of worsening suicide ideation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00289523
The ClinicalTrials.gov registry entry for NCT00289523 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00289523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00289523 about?
NCT00289523 is a clinical study titled "EEG Biomarkers for Predicting Response to Antidepressant Therapy". The purpose of this study is to evaluate the potential early EEG predictors of an individual's response to treatment with antidepressant medications. Objectives: * Prospectively confirm accuracy of current EEG biomarker algorithm * Determine preferred clinical intervention for subjects with negati...
What is the current status of trial NCT00289523?
This trial is currently completed. The enrollment target is 375 participants. The study started on 2006-01. Estimated completion is 2007-07.
Who is sponsoring clinical trial NCT00289523?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.